-
Entity
-
Individual
-
Location
-
Dendreon Corporation, 1301 2 Nd Avenue, Seattle, Washington
-
Summary
-
The estimated net worth of John Johnson is at least $2.33 M dollars as of June 20, 2024. John Johnson is the Director of Xeris Biopharma Holdings, Inc. and owns shares of Xeris Biopharma Holdings, Inc. (XERS) stock worth about $1.7 M. John Johnson is the Director of Axogen, Inc. and owns shares of Axogen, Inc. (AXGN) stock worth about $542 K. John Johnson is the Director of Verastem, Inc. and owns shares of Verastem, Inc. (VSTM) stock worth about $90.6 K.